The SAGITTARIUS clinical study a new EU-funded clinical trial leveraging the power of tumor genomics and liquid biopsy to guide the post-surgical care of patients with locoregional colon cancer.
Read moreA multidisciplinary team from the Rey Juan Carlos University and the Carlos III Health Institute has developed two new antitumor compounds that contain platinum. The results of the trials have shown t...
Read moreThe Spanish Agency for Medicines and Health Products (AEMPS) has certified compliance with the European Union Good Manufacturing Practices (GMP).
Read moreEl trabajo identifica amiloides bacterianos en el biofilm de la microbiota intestinal que exacerban las patologías causadas por α-sinucleína
Read moreOryzon Genomics, S.A., a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today that its management will give ...
Read moreUn estudio experimental en ratones puede suponer un avance en la lucha contra la resistencia a estos medicamentos. El nuevo fármaco, llamado lolamicina, mata a los microbios infecciosos sin interferi...
Read moreEl tratamiento invasivo, frente al conservador, no reduce la mortalidad, pero sí el riesgo de un nuevo infarto o la necesidad de un cateterismo urgente
Read moreThermo Fisher Scientific Inc., the world leader in serving science, announced today that the Applied Biosystems™ CytoScan™ Dx Assay and Applied Biosystems™ Chromosomal Analysis Suite (ChAS) Dx s...
Read moreUna investigadora del Hospital 12 de Octubre, centro público de la Comunidad de Madrid, lidera un estudio que demuestra que un tratamiento libre de quimioterapia reduce un 48 por ciento el riesgo de ...
Read moreThe new facility in Bleiswijk, Netherlands offers a comprehensive range of cold and ultra-cold services enabling global clinical trial innovation and biorepository storage solutions
Read moreThe combination of the antibody amivantamab and lazertinib, a drug targeting EGFR, shows better clinical benefits compared to standard treatment in patients with advanced or metastatic non-small cell ...
Read moreOryzon Genomics, S.A., announced today that the final results of the Phase IIa ALICE study evaluating iadademstat in combination with azacitidine in unfit patients with newly diagnosed acute myeloid l...
Read more